Clinical trial NCT06795815: The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease
Official title: The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco-hematologic Disease (Onco-hema Go Wish-ACP): Intervention Set up and Multicentre Feasibility Trial
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Leukemia
Multiple Mieloma
Advanced Solid Tumors
Lymphoma
Oncology
Hematologic Diseases
Keywords: Advance Care Planning
Go Wish Game
Medical Oncology
Hematology
Oncology
Palliative Care
Experimental Design Study
Mixed Methods
Lead sponsor: Azienda USL Reggio Emilia - IRCCS
Sponsor class: OTHER_GOV
First posted: 2025-01-28
Enrollment: 75
Sex: ALL
Minimum age (years): 18
Maximum age (years): 99
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: This is a mixed-method, device-free and drug-free multicenter interventional study. The study aims at facilitating end-of-life conversations within the doctor-patient relationship through the use of the Go Wish Game (GWG) and supporting patients, their caregivers and healthcare professionals to complete Advance Care Panning documentation.

The GWG helps people clarify and identify their priorities, should they be affected by a chronic, disabling and potentially non-healing illness. In fact, the GWG consists of a small deck of cards, and on each card is a concrete action or situation that may be important to a person at the end of life.

The "Onco-hema Go wish-ACP" project aims to evaluate the feasibility of a Go Wish Game-based intervention with patients with refractory lymphoma, leukemia or multiple myeloma or advanced solid tumors with prognosis \> 3 months.

In terms of secondary objectives, the study aims to.

* Evaluate and compare the intervention with hematology and oncology patients in terms of: - Other feasibility indicators; Involvement in CCP pathways; Quality of communication; Meaning of life; Impact on hope; through a series of questionnaires administered to patients and caregivers involved in the intervention
* Qualitatively assess the acceptability of the intervention in terms of recruitment and delivery with patients and caregivers through semi-structured interviews and with professionals through Focus Groups (FGs).
* To analyze the clinical records of enrolled patients in terms of: values and preferences; awareness of prognosis; end-of-life choices and shared decision-making on treatment decisions.


Eligibility criteria: Inclusion Criteria:

* ≥ 18 years age; diagnosed with refractory lymphomas, or leukemia or multiple myeloma or advanced solid tumors and estimated prognosis \> 3 months;
* able to communicate in Italian and
* to give written consent to the study.

Exclusion Criteria:

* Patients with severe cognitive impairment or serious psychiatric condition;
* refusal to participate to the study

Primary outcomes:
measure: Intervention Feasibility
timeFrame: 1 Year
Secondary outcomes:
measure: ACP Engagement;
timeFrame: 18 Months
measure: Quality of Communication;
timeFrame: 18 Months
measure: Meaning of Life;
timeFrame: 18 Months
measure: Impact on patients' hope
timeFrame: 18 Months
measure: Acceptability
timeFrame: 18 Months
measure: ACP documentation
timeFrame: 18 Months
Other outcomes:
Locations:
city: Reggio Emilia
country: Italy
facility: AziendaUSL IRCCS Reggio Emilia
Study officials:
References: